Explore the details of the Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al case under case number 1:2025cv00719 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:2025cv00719
Filing Date
Jun 9, 2025
Cause of Action
Patent Infringement
Status
OPEN
Case Link
View Case
Nature of Suit
830

Plaintiffs

The following plaintiffs are involved in this case, with their respective legal representatives for the case.

CompanyRepresented By
Bayer AG
Morris, Nichols, Arsht & Tunnell LLP
Bayer Pharma AG
Morris, Nichols, Arsht & Tunnell LLP
Janssen Pharmaceuticals, Inc.
Morris, Nichols, Arsht & Tunnell LLP

Defendants

The following defendants are involved in this case, with their respective legal representatives for the case.

CompanyRepresented By
Macleods Pharma USA, Inc. -
Macleods Pharmaceuticals Ltd. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 2, 2025Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/2/2025 (nms). (Entered: 07/02/2025)-
Jul 2, 2025 SUMMONS Returned Executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc..Macleods Pharma USA, Inc. served on 7/1/2025, answer due 7/22/2025. (Fahnestock, Derek) (Entered: 07/02/2025)SUMMONS
Jul 2, 2025 SUMMONS Returned Executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc..Macleods Pharmaceuticals Ltd. served on 7/1/2025, answer due 7/22/2025. (Fahnestock, Derek) (Entered: 07/02/2025)SUMMONS
Jun 16, 2025REDACTED VERSION of 3 Complaint, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(Fahnestock, Derek) Modified on 6/16/2025 (nms). (Entered: 06/16/2025)REDACTED VERSION
Jun 9, 2025ORDER Granting 1 Motion for Leave to File Complaint Under Seal. A redacted version of the complaint shall be filed within seven days. Signed by Judge Richard G. Andrews on 6/9/2025. (aas) (Entered: 06/09/2025)ORDER
Jun 9, 2025Summons Issued as to Macleods Pharma USA, Inc. on 6/9/2025; Macleods Pharmaceuticals Ltd. on 6/9/2025. (Attachments: # 1 Summons Issued)(mrr) (Entered: 06/09/2025)-
Jun 9, 2025 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)-
Jun 9, 2025 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)-
Jun 9, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US, 10,828,310. (mrr) (Entered: 06/09/2025)-
Jun 9, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 06/09/2025)-
Jun 9, 2025[SEALED] COMPLAINT with Jury Demand against Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. (Filing fee $ 405, receipt number ADEDC-4706261) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(mrr) (Entered: 06/09/2025)-
Jun 9, 2025 DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)DECLARATION
Jun 9, 2025MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)MOTION